Literature DB >> 14688214

Immunohistochemical assessment of the peripheral benzodiazepine receptor in human tissues.

Estelle Bribes1, Dominique Carrière, Catherine Goubet, Sylvaine Galiègue, Pierre Casellas, Joêlle Simony-Lafontaine.   

Abstract

Exhaustive analysis of the location of the peripheral benzodiazepine receptor (PBR) both at the subcellular and the tissue level is warranted to gain a better understanding of its biological roles. To date, many studies have been performed in animal models, such as rat, mouse, and pig, that yielded important information. However, only a few reports were dedicated to the analysis of PBR expression in humans. To enlarge on previous studies, we investigated PBR expression in different human organs using the monoclonal antibody 8D7 that specifically recognized the human PBR. First, we performed electron microscopic analysis that for the first time unambiguously demonstrated the localization of the PBR on the outer mitochondrial membrane. Second, focusing our analysis on human tissues for which information on PBR expression is sparse (lung, stomach, small intestine, colon, thyroid, adrenal gland, pancreas, breast, prostate, ovary), we found that PBR exhibits selective localization. This characterization of PBR localization in human tissues should provide important insights for the understanding of PBR functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688214     DOI: 10.1177/002215540405200103

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  23 in total

Review 1.  Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.

Authors:  Amani Batarseh; Vassilios Papadopoulos
Journal:  Mol Cell Endocrinol       Date:  2010-06-30       Impact factor: 4.102

2.  Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study.

Authors:  Akihiro Takano; Balázs Gulyás; Andrea Varrone; Per Karlsson; Nils Sjoholm; Stig Larsson; Cathrine Jonsson; Richard Odh; Richard Sparks; Nabil Al Tawil; Anja Hoffmann; Torsten Zimmermann; Andrea Thiele; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

3.  Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans.

Authors:  Christopher J Endres; Jennifer M Coughlin; Kenneth L Gage; Crystal C Watkins; Michael Kassiou; Martin G Pomper
Journal:  J Nucl Med       Date:  2012-01-12       Impact factor: 10.057

4.  Overexpression of translocator protein in inflammatory bowel disease: potential diagnostic and treatment value.

Authors:  Mariano A Ostuni; Leeyah Issop; Gabriel Péranzi; Francine Walker; Magali Fasseu; Carole Elbim; Vassilios Papadopoulos; Jean-Jacques Lacapere
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

5.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

Authors:  M Cosenza-Nashat; M-L Zhao; H-S Suh; J Morgan; R Natividad; S Morgello; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12-11       Impact factor: 8.090

6.  Translocator Protein (TSPO) Affects Mitochondrial Fatty Acid Oxidation in Steroidogenic Cells.

Authors:  Lan N Tu; Amy H Zhao; Mahmoud Hussein; Douglas M Stocco; Vimal Selvaraj
Journal:  Endocrinology       Date:  2016-01-07       Impact factor: 4.736

7.  Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription.

Authors:  Hui-Jie Wang; Jinjiang Fan; Vassilios Papadopoulos
Journal:  Cell Tissue Res       Date:  2012-08-07       Impact factor: 5.249

Review 8.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair.

Authors:  Ming-Kai Chen; Tomás R Guilarte
Journal:  Pharmacol Ther       Date:  2008-02-09       Impact factor: 12.310

9.  Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity.

Authors:  Gary D Friedman; Sheng-Fang Jiang; Natalia Udaltsova; Charles P Quesenberry; James Chan; Laurel A Habel
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

10.  A patient with stress-related onset and exacerbations of Graves disease.

Authors:  Roberto Vita; Daniela Lapa; Giuseppe Vita; Francesco Trimarchi; Salvatore Benvenga
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.